(Q24250284)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1 reference

1

H L Halliday

H L

Halliday

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R A Ehrenkranz

2

R A

Ehrenkranz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

CD001144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Pulse dexamethasone does not impair growth and body composition of very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Dexamethasone therapy increases infection in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

A three year follow up of preterm infants after moderately early treatment with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Early versus late dexamethasone treatment in preterm infants at risk for chronic lung disease: a randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Clinical trials of postnatal corticosteroids: inhaled and systemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

7 January 2021

Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

7 January 2021

A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

7 January 2021

Using cerebral palsy data in the evaluation of neonatal intensive care: a warning

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

7 January 2021

Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

7 January 2021

Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001144

7 January 2021

10.1002/14651858.CD001144

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json

release_elimdh2y6rerji6mj5ejkkq4yu

6 November 2019

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796416%20AND%20SRC:MED&resulttype=core&format=json